Skip to Content

WATSON 3614 (Ropinirole hydrochloride extended-release 8 mg)

Pill imprint WATSON 3614 has been identified as Ropinirole hydrochloride extended-release 8 mg.

Ropinirole is used in the treatment of parkinson's disease; restless legs syndrome; periodic limb movement disorder; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 8 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ropinirole hydrochloride extended-release 8 mg WATSON 3614
Ropinirole hydrochloride extended-release 8 mg WATSON 3614
Discount Card Promo
Ropinirole hydrochloride extended-release
Imprint:
WATSON 3614
Strength:
8 mg
Color:
Red
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Watson Laboratories, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide